New eye implant could ease glaucoma pressure
NCT ID NCT06964061
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This study tests a single dose of a dissolvable eye implant (PA5346) in 12 adults with open-angle glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure and how long it takes to dissolve. This is an early-stage trial, so it focuses on safety and basic effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA (OAG) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cataract & Eye Surgery Centre
Doncaster, Victoria, 3109, Australia
-
Cerulea Pty Ltd
East Melbourne, Victoria, 3002, Australia
-
Melbourne Eye Specialists
Melbourne, Victoria, 3000, Australia
Conditions
Explore the condition pages connected to this study.